Immunology and immunotherapy of neuroblastoma.
Semin. Cancer Biol., Oct;21(4):229-37 (2011)
Sparse representation and Bayesian detection of genome copy number alterations from microarray data.
Bioinformatics., Feb;24(3):309-18 (2008)
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
Pediatr Blood Cancer., Oct;53(4):563-9 (2009)
ATM is down-regulated by N-Myc-regulated microRNA-421.
Proc. Natl. Acad. Sci. U.S.A., Jan;107(4):1506-11 (2010)
Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.
Leukemia., Jun;17(6):1068-77 (2003)
Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2.
J. Exp. Med., May;199(9):1213-21 (2004)
TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Cancer., Oct;101(8):1873-81 (2004)
Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
Cancer., Jan;103(1):174-80 (2005)
Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma.
J. Clin. Invest., Sep;117(9):2702-12 (2007)
Cdc6 knockdown inhibits human neuroblastoma cell proliferation.
Mol. Cell. Biochem., Apr;311(1-2):189-97 (2008)
Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
Cancer Res., May;58(10):2209-16 (1998)
Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulating.
Cancer Immunol. Immunother., Feb;48(11):603-12 (2000)
Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma.
Med. Pediatr. Oncol., Dec;35(6):647-50 (2000)
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
J. Immunol., Sep;167(6):3114-22 (2001)
Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophi
Blood., Jun;99(11):4166-73 (2002)
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.
J. Clin. Oncol., Apr;13(4):894-901 (1995)
Telomerase expression in primary neuroblastomas.
Eur. J. Cancer., Oct;33(12):1929-31 (1997)
Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
Cancer Res., Dec;58(23):5396-405 (1998)
The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.
Cancer Res., Mar;59(6):1327-36 (1999)
Expression of a developmental stage-specific antigen by neuronal precursor cells of human fetal cerebellum.
J. Neuroimmunol., Nov;20(1):3-14 (1988)